PLURISTEM THERAPEUTICS INC (PSTI) Stock Analyst Ratings
USA - NASDAQ:PSTI - US72940R3003 - Common Stock
1 USD
-0.03 (-2.91%)
1.03 USD
+0.03 (+3%)
ChartMill assigns a Buy % Consensus number of 83% to PSTI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.57. This target is 257% above the current price.
PSTI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PSTI.
In the previous month the buy percentage consensus was at a similar level.
PSTI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-20 | Alliance Global Partners | Maintains | Buy |
| 2021-05-04 | Alliance Global Partners | Initiate | Buy |
PLURISTEM THERAPEUTICS INC / PSTI FAQ
What is the price target for PSTI stock?
8 analysts have analysed PSTI and the average price target is 3.57 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 1.
How do analysts rate PLURISTEM THERAPEUTICS INC (PSTI)?
The consensus rating for PLURISTEM THERAPEUTICS INC (PSTI) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed PLURISTEM THERAPEUTICS INC (PSTI)?
The number of analysts covering PLURISTEM THERAPEUTICS INC (PSTI) is 8.